Merck & Co. Inc.

Pharmaceuticals
United States
Executive 1Mr. Kenneth C. Frazier, Chairman; President; Chief Executive Officer | Chairman; President; Chief Executive Officer
Executive 2Mr. Robert M. Davis, Executive Vice President; Chief Financial Officer | Chairman; Executive Board Member
Earnings Per Share Growth (%)176.87%
Cost of Goods Sold (US$ Millions)$16,768
Current Liabilities (US$ Millions)$18,766
Total Assets (US$ Millions)$33,173
Long Term Debt (Millions)$18,699
Return on Equity23.95%
Revenue (US$ Millions)$42,237
Total Company Assets$98,335
Revenue Growth (%)-4.08%
Net Income (US$ Millions)$11,920
Earnings Per Share (US$)$4.07
Total Equity (US$ Millions)$48,647
Profit Margin (%)28.22%
Debt To Equity Ratio (%)0.38%
Inventories (Millions)$5,571